SQ-SHED Research Program
Congenital Hypoganglionosis
ResearchActive (AMED grant funded)
Key Facts
Indication
Congenital Hypoganglionosis
Phase
Research
Status
Active (AMED grant funded)
Company
About Kidswell Bio
Japanese biotech developing SHED-based cell therapies for pediatric neurological disorders and operating a dual business model with biosimilars.
View full company profile